GURUFOCUS.COM » STOCK LIST » USA » OTCPK » Biomark Diagnostics Inc (OTCPK:BMKDF) » Definitions » Net Margin %
Switch to:

Biomark Diagnostics (OTCPK:BMKDF) Net Margin %

: -1,163.89% (As of Jun. 2022)
View and export this data going back to 2015. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Biomark Diagnostics's Net Income for the three months ended in Jun. 2022 was $-0.33 Mil. Biomark Diagnostics's Revenue for the three months ended in Jun. 2022 was $0.03 Mil. Therefore, Biomark Diagnostics's net margin for the quarter that ended in Jun. 2022 was -1,163.89%.

The historical rank and industry rank for Biomark Diagnostics's Net Margin % or its related term are showing as below:

BMKDF' s Net Margin % Range Over the Past 10 Years
Min: -3304.55   Med: -1883.27   Max: -461.98
Current: -2005


BMKDF's Net Margin % is ranked worse than
93.91% of 230 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.02 vs BMKDF: -2005.00

Biomark Diagnostics (OTCPK:BMKDF) Net Margin % Historical Data

The historical data trend for Biomark Diagnostics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -461.98 - -3,304.55

Biomark Diagnostics Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -1,385.00 -3,041.67 -1,163.89

Biomark Diagnostics (OTCPK:BMKDF) Net Margin % Competitive Comparison

For the Diagnostics & Research subindustry, Biomark Diagnostics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Biomark Diagnostics (OTCPK:BMKDF) Net Margin % Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's Net Margin % falls into.



Biomark Diagnostics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Biomark Diagnostics's Net Margin for the fiscal year that ended in Mar. 2022 is calculated as

Net Margin=Net Income (A: Mar. 2022 )/Revenue (A: Mar. 2022 )
=-1.1484992101106/0.034755134281201
=-3,304.55 %

Biomark Diagnostics's Net Margin for the quarter that ended in Jun. 2022 is calculated as

Net Margin=Net Income (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-0.3272414870353/0.028116213683224
=-1,163.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomark Diagnostics  (OTCPK:BMKDF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Biomark Diagnostics Net Margin % Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics (OTCPK:BMKDF) Business Description

Biomark Diagnostics logo
Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.

Biomark Diagnostics (OTCPK:BMKDF) Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
premium membership